Donald Ingber
Donald Ingber, MD, PhD
Founding Director
Wyss Institute for Biologically Inspired Engineering
Harvard University
Nathalie Sauvonnet, PhD
Nathalie Sauvonnet, PhD
Research Director
Institut Pasteur
William Proctor, PhD, DABT
William Proctor, PhD, DABT
Sr. Director, Sr. Scientist
Predictive Toxicology
Safety Assessment
Don McKenzie
Don McKenzie, PhD
Vice President, Head Global Drug Metabolism & Environmental Sciences

Human Biology: An Exploration of Organs-on-Chips

Broadcast Date: 
  • Time: 

Biologic drugs comprise 40 percent of the current drug development pipeline. Existing in vitro and animal models are limited in their ability to evaluate the safety and efficacy of these drugs in humans. These limitations often result in development delays and increased costs.

Organs-on-chips emulate human biology by providing a micro-engineered environment lined with living human cells and tissues. Each chip recreates the natural physiology and mechanical forces that cells experience within the human body. 

This digital event brings together the world’s leading experts for an extensive exploration of how organs-on-chips provide a far more predictive model of human biology. Together, we’ll discover the latest developments of how this advanced technology is transforming therapeutic research. We’ll also feature informative breakout sessions on neurology, inflammation, infectious diseases, and the future of organs-on-chips.

Join us as we open new windows into human biology. Attend the event on alternative in vitro tools.

emulate bio logo

Comments are closed.